COVID 19 Policy / Procedure:
Please click here for information regarding COVID-19 main office closure, emergency patient procedures, glasses, and contact lenses.

alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

TearLab®/LipiView®/LipiFlow®

Diagnosing and treating dry eyes

A large segment of the population suffers from dry eye symptoms. We use advanced technology to diagnose the causes and provide treatment for dry eye.

TearLab® provides information about tear composition to help diagnose the severity of dry eye and to manage patient progress with treatments.​

The leading cause of dry eye symptoms is Meibomian Gland Dysfunction (MGD), a condition that occurs when the protective lipid (oil) that normally flows from meibomian glands in the eyelid is slowed or stopped due to blockage in the glands.
LipiView® II with Dynamic Meibomian Imaging™(DMI™) is the only instrument available that assesses both meibomian gland function and structure to detect MGD in its earliest stages.

It accurately measures lipid layer thickness, evaluates blink rate, and visualizes meibomian gland structure.

With precise heat and pulsation, LipiFlow®, the only FDA-approved device to treat MGD, removes gland blockage, allowing them to resume natural production of oil needed for healthy tears.